International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies

Br J Dermatol. 2003 May:148 Suppl 63:3-10. doi: 10.1046/j.1365-2133.148.s63.1.x.

Authors

C Ellis¹, T Luger, D Abeck, R Allen, R A C Graham-Brown, Y De Prost, L F Eichenfield, C Ferrandiz, A Giannetti, J Hanifin, J Y M Koo, D Leung, C Lynde, J Ring, R Ruiz-Maldonado, J-H Saurat; ICCAD II Faculty

Affiliation

¹ Department of Dermatology, University of Michigan Medical Center, Ann Arbor, MI, U.S.A. cellis@med.umich.edu

PMID: 12694268
DOI: 10.1046/j.1365-2133.148.s63.1.x

No abstract available

Publication types

Consensus Development Conference
Review

MeSH terms

Administration, Topical
Chemotherapy, Adjuvant
Clinical Trials as Topic
Dermatitis, Atopic / etiology
Dermatitis, Atopic / therapy*
Dermatologic Agents / therapeutic use
Humans
Immunosuppressive Agents / therapeutic use
Practice Guidelines as Topic
Tacrolimus / adverse effects
Tacrolimus / analogs & derivatives*
Tacrolimus / therapeutic use

Substances

Dermatologic Agents
Immunosuppressive Agents
pimecrolimus
Tacrolimus